特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
943764

稀少遺伝性疾患検査の市場規模:市場シェア・動向分析、疾患タイプ(神経、内分泌&代謝疾患)、技術(NGS、FISH)、専門分野、最終用途、地域別のセグメント予測(2020年~2027年)

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease Type (Neurological, Endocrine & Metabolism Diseases), By Technology (NGS, FISH), By Specialty, By End Use, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 208 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
稀少遺伝性疾患検査の市場規模:市場シェア・動向分析、疾患タイプ(神経、内分泌&代謝疾患)、技術(NGS、FISH)、専門分野、最終用途、地域別のセグメント予測(2020年~2027年)
出版日: 2020年06月01日
発行: Grand View Research, Inc.
ページ情報: 英文 208 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の稀少遺伝性疾患検査の市場規模は、2027年までの間に10.8%のCAGRで拡大してする見通しで、2027年には18億米ドルに達すると予測されています。稀少疾患の正確な特定のための診察、従来の検査方法による診断の遅延、それに伴う医療費の増加により、稀少疾患を正確かつタイムリーに特定するための遺伝子検査法の採用に拍車がかかっています。

当レポートは世界の稀少遺伝性疾患検査市場について調査しており、市場の動向や見通し、疾患タイプ・技術・専門分野・最終用途・地域別の市場分析、競合・ベンダー情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査手法

第3章 市場の変数、動向および範囲

  • 市場セグメンテーション
  • 産業ピラミッド分析
  • 技術の浸透と成長の見通しマッピング
  • SWOT分析:要因別
  • ポーターのファイブフォース分析

第4章 市場の展望

  • 市場力学
    • 市場成長要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 規制の枠組み
    • 米国
    • 欧州
    • 中国
    • 日本
  • 主要取引と戦略的提携分析
    • 新製品発売
    • 合併と買収
    • 提携
  • 企業の市場シェア分析

第5章 市場分析:疾患タイプ別

  • 動向分析
  • 神経疾患
  • 免疫疾患
  • 血液疾患
  • 内分泌および代謝疾患
  • 筋骨格障害
  • 心血管疾患(CVD)
  • 皮膚科疾患
  • その他

第6章 市場分析:技術別

  • 動向分析
  • 次世代シーケンス(NGS)
  • アレイテクノロジー
  • PCR検査
  • FISH
  • サンガーシーケンス
  • 核型分析

第7章 市場分析:専門分野別

  • 分子
  • 染色体
  • バイオケミカル

第8章 市場分析:最終用途別

  • 研究室・CRO
  • 診断研究所
  • 病院・診療所

第9章 市場分析:地域別

  • 動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ

第10章 企業プロファイル

図表

List of Tables

  • Table 1 Inheritance pattern of rare diseases
  • Table 2 Distribution of registries by EU countries
  • Table 3 Rare disease policy and regulatory frameworks in EU, updated as of 2017
  • Table 4 North America rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 5 North America rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 6 North America NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 7 North America rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 8 North America rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 9 U.S. rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 10 U.S. rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 11 U.S. NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 12 U.S. rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 13 U.S. rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 14 Canada rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 15 Canada rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 16 Canada NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 17 Canada rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 18 Canada rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 19 Europe rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 20 Europe rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 21 Europe NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 22 Europe rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 23 Europe rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 24 Germany rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 25 Germany rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 26 Germany NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 27 Germany rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 28 Germany rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 29 U.K. rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 30 U.K. rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 31 U.K. NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 32 U.K. rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 33 U.K. rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 34 Spain rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 35 Spain rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 36 Spain NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 37 Spain rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 38 Spain rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 39 France rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 40 France rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 41 France NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 42 France rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 43 France rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 44 Italy rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 45 Italy rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 46 Italy NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 47 Italy rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 48 Italy rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 49 Netherlands rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 50 Netherlands rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 51 Netherlands NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 52 Netherlands rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 53 Netherlands rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 54 Asia Pacific rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 55 Asia Pacific rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 56 Asia Pacific NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 57 Asia Pacific rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 58 Asia Pacific rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 59 Japan rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 60 Japan rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 61 Japan NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 62 Japan rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 63 Japan rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 64 China rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 65 China rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 66 China NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 67 China rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 68 China rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 69 India rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 70 India rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 71 India NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 72 India rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 73 India rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 74 South Korea rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 75 South Korea rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 76 South Korea NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 77 South Korea rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 78 South Korea rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 79 Singapore rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 80 Singapore rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 81 Singapore NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 82 Singapore rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 83 Singapore rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 84 Australia rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 85 Australia rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 86 Australia NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 87 Australia rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 88 Australia rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 89 South East Asia rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 90 South East Asia rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 91 South East Asia NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 92 South East Asia rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 93 South East Asia rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 94 Latin America rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 95 Latin America rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 96 Latin America NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 97 Latin America rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 98 Latin America rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 99 Brazil rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 100 Brazil rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 101 Brazil NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 102 Brazil rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 103 Brazil rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 104 MEA rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 105 MEA rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 106 MEA NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 107 MEA rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 108 MEA rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)
  • Table 109 South Africa rare disease genetic testing market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
  • Table 110 South Africa rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 111 South Africa NGS - based rare disease genetic testing market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 112 South Africa rare disease genetic testing market estimates & forecasts, by specialty, 2016 - 2027 (USD Million)
  • Table 113 South Africa rare disease genetic testing market estimates & forecasts, by end - use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Rare disease genetic testing market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Industry pyramid analysis
  • Fig. 5 Industry pyramid analysis
  • Fig. 6 Market research approaches
  • Fig. 7 Value - chain - based sizing & forecasting
  • Fig. 8 Industry pyramid analysis
  • Fig. 9 Industry pyramid analysis
  • Fig. 10 Rare diseases by inheritance pattern
  • Fig. 11 Definition of rare diseases by region
  • Fig. 12 Prevalence of Multiple sclerosis
  • Fig. 13 Prevalence rate of selected rare diseases in 2017
  • Fig. 14 Distribution of research projects for rare diseases
  • Fig. 15 Penetration of technologies in the rare disease diagnostics market
  • Fig. 16 QFD modeling for market share assessment for specialty scope, by type
  • Fig. 17 Penetration by end - use settings
  • Fig. 18 Regional analysis for rare disease genetic testing market
  • Fig. 19 QFD modeling for company market share assessment
  • Fig. 20 QFD modeling workflow for company market share assessment
  • Fig. 21 Rare disease genetic testing market segmentation
  • Fig. 22 Ancillary market analysis
  • Fig. 23 Penetration and growth prospect mapping for technology, 2019
  • Fig. 24 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 25 Porter's Five Forces Analysis
  • Fig. 26 Rare disease genetic testing market driver impact
  • Fig. 27 Distribution of registries by affiliation in EU
  • Fig. 28 Illumina's sequencing cost per MB
  • Fig. 29 Rare disease genetic testing market restraint impact
  • Fig. 30 Illumina's sequencing cost per MB
  • Fig. 31 Company market share analysis
  • Fig. 32 Rare disease genetic testing market: Disease type outlook and key takeaways
  • Fig. 33 Rare disease genetic testing market: Disease type movement analysis
  • Fig. 34 Global genetic testing market for rare neurology diseases, 2016 - 2027 (USD Million)
  • Fig. 35 Global genetic testing market for rare immunologic disorders, 2016 - 2027 (USD Million)
  • Fig. 36 Global genetic testing market for rare hematology diseases, 2016 - 2027 (USD Million)
  • Fig. 37 Global genetic testing market for rare endocrine & metabolism diseases, 2016 - 2027 (USD Million)
  • Fig. 38 Global genetic testing market for rare cancer forms, 2016 - 2027 (USD Million)
  • Fig. 39 Global genetic testing market for rare musculoskeletal disorders, 2016 - 2027 (USD Million)
  • Fig. 40 Global genetic testing market for rare cardiovascular disorders, 2016 - 2027 (USD Million)
  • Fig. 41 Global genetic testing market for rare dermatology diseases, 2016 - 2027 (USD Million)
  • Fig. 42 Global genetic testing market for other rare diseases, 2016 - 2027 (USD Million)
  • Fig. 43 Rare disease genetic testing market: Technology outlook and key takeaways
  • Fig. 44 Rare disease genetic testing market: Technology movement analysis
  • Fig. 45 DNA sequencing cost per genome
  • Fig. 46 Global NGS - based Rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 47 Comparison of growth in genetic testing units for exome & targeted exome, custom genes, large (>500 gene) panels
  • Fig. 48 Global WES - based rare disease genetic testing market 2016 - 2027 (USD Million)
  • Fig. 49 Global WGS - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 50 Global array technology - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 51 Global PCR - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 52 Global FISH - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 53 Global sanger sequencing - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 54 Global karyotyping - based rare disease genetic testing market, 2016 - 2027 (USD Million)
  • Fig. 55 Rare disease genetic testing market: Specialty outlook and key takeaways
  • Fig. 56 Rare disease genetic testing market: Specialty movement analysis
  • Fig. 57 DNA sequencing cost per Mb
  • Fig. 58 Global molecular genetic tests market for rare diseases, 2016 - 2027 (USD million)
  • Fig. 59 Global chromosomal genetic tests market for rare diseases, 2016 - 2027 (USD million)
  • Fig. 60 Global biochemical genetic tests market for rare diseases, 2016 - 2027 (USD million)
  • Fig. 61 Rare disease genetic testing market: End - use outlook and key takeaways
  • Fig. 62 Rare disease genetic testing market: End - use movement analysis
  • Fig. 63 Global research laboratories & CROs - based rare disease genetic testing market, 2016 - 2027 (USD million)
  • Fig. 64 Global diagnostic laboratories - based rare disease genetic testing market, 2016 - 2027 (USD million)
  • Fig. 65 Global hospitals & clinics - based rare disease genetic testing market, 2016 - 2027 (USD million)
  • Fig. 66 Rare disease genetic testing market: Regional outlook and key takeaways
  • Fig. 67 Rare disease genetic testing market: Regional movement analysis
  • Fig. 68 North America
  • Fig. 69 North America rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 70 U.S.
  • Fig. 71 U.S. rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 72 Canada
  • Fig. 73 Canada rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 74 Europe
  • Fig. 75 Europe rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 76 Germany
  • Fig. 77 Germany rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 78 U.K.
  • Fig. 79 U.K. rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 80 Spain
  • Fig. 81 Spain rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 82 France
  • Fig. 83 France rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 84 Italy
  • Fig. 85 Italy rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 86 Netherlands
  • Fig. 87 Netherlands rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 88 Asia - Pacific
  • Fig. 89 Asia - Pacific rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 90 Japan
  • Fig. 91 Japan rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 92 China
  • Fig. 93 China rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 94 India
  • Fig. 95 India rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 96 South Korea
  • Fig. 97 South Korea rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 98 Singapore
  • Fig. 99 Singapore rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 100 Australia
  • Fig. 101 Australia rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 102 South East Asia
  • Fig. 103 South East Asia rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 104 Latin America
  • Fig. 105 Latin America rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 106 Brazil
  • Fig. 107 Brazil rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 108 Middle East & Africa
  • Fig. 109 MEA rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 110 South Africa
  • Fig. 111 South Africa rare disease genetic testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 112 Strategy framework
  • Fig. 113 Company participant categorization
目次
Product Code: GVR-4-68038-695-0

Rare Disease Genetic Testing Market Growth & Trends

The global rare disease genetic testing market size is expected to reach USD 1.8 billion by 2027 expanding at a CAGR of 10.8% over the forecast period, according to a new report by Grand View Research, Inc. Conventional test methods provide delayed diagnosis. Moreover, patients need to visit physicians to correctly identify a rare condition, leading to an increased healthcare spending. This has spurred the adoption of genetic test methods for accurate and timely identification of rare conditions.

Ongoing scientific advances in this area have created new opportunities for the companies to develop solutions that can impact the management of the rare condition. Collaborations are being undertaken not only across diverse medical and scientific domains but also with various stakeholder groups, such as researchers, patients, and regulators, for new test development, thereby driving the market.

For instance, in October 2018, PerkinElmer Genomics signed an agreement with Sanofi Genzyme to introduce a free genetic testing program called the Lantern Project. The initiative was designed for patients who have or are suspected of having, certain types of lysosomal storage disorders, including Gaucher disease.

Rare Disease Genetic Testing Market Report Highlights

  • Neurological disorders accounted for the major revenue share in 2019 owing to availability of a substantial number of test offerings by various companies, such as Invitae and Centogene
  • Furthermore, the National Institute of Neurological Disorders and Stroke supports research studies for a wide range of diseases, thereby positively impacting the segment growth
  • Availability and adoption of NGS-based gene panels for cancer, neurologic disease, CVDs, and other rare disease testing has driven the NGS segment
  • NGS has enabled rapid and cost-effective genetic testing by helping in determining the relevance of de novo and mosaic mutations
  • It has also helped in detecting the wide phenotypic spectrum of genes, digenic inheritance, and presence of more than one rare condition in the same individual
  • Thus, a significant decline in the cost of NGS has driven its adoption for molecular testing, contributing to the large share of molecular genetic tests
  • Laboratories are engaged in conducting a substantial number of genetic tests. This includes labs that are accredited with CLIA for clinical cytogenetics, pathology, and chemistry, among other specialties
  • Furthermore, regulatory bodies play a major role in the growth of this segment, as they help laboratories conduct effective and safe genetic testing, leading to their dominance as end-user of the market
  • North America led the global market in 2019 owing to the presence of key research and diagnostic laboratories in U.S.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Summary

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Model
    • 2.3.1 Market study, by disease
    • 2.3.2 Market study, by technology
    • 2.3.3 Market study, by specialty
    • 2.3.4 Market study, by end use
    • 2.3.5 Regional analysis
    • 2.3.6 Company Market Share Analysis

Chapter 3 Rare Disease Genetic Testing Market Vavriables, Trends, & Scope

  • 3.1 Market Segmentation
  • 3.2 Rare Disease Genetic Testing Market: Industry Pyramid Analysis
    • 3.2.1 Parent market outlook
    • 3.2.2 Related/ancillary market outlook
  • 3.3 Penetration and Growth Prospect Mapping for Technology, 2019
  • 3.4 SWOT Analysis, by Factor (Political & Legal, Economic, And Technological)
  • 3.5 Porter's Five Forces Analysis

Chapter 4 Rare Disease Genetic Testing Market Industry Outlook

  • 4.1 Market Dynamics
    • 4.1.1 Market driver analysis
      • 4.1.1.1 Expanding patient registry for rare disease
      • 4.1.1.2 Declinig sequencing cost & Technological advancements in Disease diagnosis
      • 4.1.1.3 Launch of programs & NEw product Development in Rare Disease diagnosis
    • 4.1.2 Market restraint analysis
      • 4.1.2.1 Absence of effective Diagnosis Framework
      • 4.1.2.2 Technical challenges associated with genetic tests & data management
    • 4.1.3 Market Opportunity Analysis
      • 4.1.3.1 Government & regulatory support for rare disease diagnosis
    • 4.1.4 Market Challenge Analysis
      • 4.1.4.1 Limited awareness pertaning to the rare disease conditions
  • 4.2 Regulatory Framework
    • 4.2.1 U.S.
    • 4.2.2 Europe
    • 4.2.3 China
    • 4.2.4 Japan
  • 4.3 Major Deals And Strategic Alliances Analysis
    • 4.3.1 New product launch
    • 4.3.2 Mergers and acquisitions
    • 4.3.3 Partnerships
  • 4.4 Rare Disease Genetic Testing Market: Company Market Share Analysis

Chapter 5 Rare Disease Genetic Testing Market: Disease Type Movement Analysis

  • 5.1 Rare Disease Genetic Testing Market: Disease Type Movement Analysis
  • 5.2 Neurologic Diseases
    • 5.2.1 Global genetic testing market for rare neurology diseases, 2016 - 2027 (USD Million)
  • 5.3 Immunologic Disorders
    • 5.3.1 Global genetic testing market for rare immunologic disorders, 2016 - 2027 (USD Million)
  • 5.4 Hematology Diseases
    • 5.4.1 Global genetic testing market for rare hematology diseases, 2016 - 2027 (USD Million)
  • 5.5 Endocrine & Metabolism Diseases
    • 5.5.1 Global genetic testing market for rare endocrine & metabolism diseases, 2016 - 2027 (USD Million)
  • 5.6 Cancer
    • 5.6.1 Global genetic testing market for rare cancer forms, 2016 - 2027 (USD Million)
  • 5.7 Musculoskeletal Disorders
    • 5.7.1 Global genetic testing market for rare musculoskeletal disorders, 2016 - 2027 (USD Million)
  • 5.8 Cardiovascular Disorders (CVD)
    • 5.8.1 Global genetic testing market for rare cardiovascular disorders, 2016 - 2027 (USD Million)
  • 5.9 Dermatology Diseases
    • 5.9.1 Global genetic testing market for rare dermatology diseases, 2016 - 2027 (USD Million)
  • 5.10 Other Rare Diseases
    • 5.10.1 Global genetic testing market for other rare diseases, 2016 - 2027 (USD Million)

Chapter 6 Rare Disease Genetic Testing Market: Technology Movement Analysis

  • 6.1 Rare Disease Genetic Testing Market: Technology Movement Analysis
  • 6.2 Next Generation Sequencing (NGS)
    • 6.2.1 Global NGS - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
    • 6.2.2 Whole Exome Sequencing (WES)
      • 6.2.2.1 Global WES - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
    • 6.2.3 Whole Genome Sequencing (WGS)
      • 6.2.3.1 Global WGS - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 6.3 Array Technology
    • 6.3.1 Global array technology - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 6.4 PCR - based Testing
    • 6.4.1 Global PCR - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 6.5 FISH
    • 6.5.1 Global FISH - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 6.6 Sanger Sequencing
    • 6.6.1 Global Sanger Sequencing - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 6.7 Karyotyping
    • 6.7.1 Global karyotyping - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)

Chapter 7 Rare Disease Genetic Testing Market: Speciality Business Analysis

  • 7.1 Molecular Genetic Tests
    • 7.1.1 Global molecular genetic tests market for rare diseases, 2016 - 2027 (USD Million)
  • 7.2 Chromosomal Genetic Tests
    • 7.2.1 Global chromosomal genetic tests market for rare diseases, 2016 - 2027 (USD Million)
  • 7.3 Biochemical Genetic Tests
    • 7.3.1 Global biochemical genetic tests market for rare diseases, 2016 - 2027 (USD Million)

Chapter 8 Rare Disease Genetic Testing Market: End - Use Business Analysis

  • 8.1 Research Laboratories & CROs
    • 8.1.1 Global research laboratories & CROs - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Global diagnostic laboratories - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)
  • 8.3 Hospitals & Clinics
    • 8.3.1 Global hospitals & clinics - based Rare Disease Genetic Testing Market, 2016 - 2027 (USD Million)

Chapter 9 Rare Disease Genetic Testing Market: Regional Movement Analysis

  • 9.1 Rare Disease Genetic Testing Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.2.2.2 U.S. Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.2.2.3 U.S. Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.2.2.4 U.S. Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.2.3.2 Canada Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.2.3.3 Canada Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.2.3.4 Canada Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Canada Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.2.2 Canada Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.2.3 Canada Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.2.4 Canada Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.3.2 U.K. Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.3.3 U.K. Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.3.4 U.K. Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.3.4 Spain
      • 9.3.4.1 Spain Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.4.2 Spain Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.4.3 Spain Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.4.4 Spain Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.3.5 France
      • 9.3.5.1 France Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.5.2 France Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.5.3 France Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.5.4 France Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.3.6 Italy
      • 9.3.6.1 Italy Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.6.2 Italy Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.6.3 Italy Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.6.4 Italy Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.3.7 The Netherlands
      • 9.3.7.1 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.3.7.2 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.3.7.3 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.3.7.4 The Netherlands Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.2.2 Japan Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.2.3 Japan Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.2.4 Japan Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.3.2 China Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.3.3 China Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.3.4 China Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.4.2 India Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.4.3 India Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.4.4 india Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.5.2 South Korea Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.5.3 South Korea Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.5.4 South Korea Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.6 Singapore
      • 9.4.6.1 Singapore Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.6.2 Singapore Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.6.3 Singapore Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.6.4 Singapore Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.7 Australia
      • 9.4.7.1 Australia Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.7.2 Australia Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.7.3 Australia Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.7.4 Australia Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
    • 9.4.8 South East Asia
      • 9.4.8.1 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.4.8.2 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.4.8.3 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.4.8.4 South East Asia Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.5.2.2 Brazil Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.5.2.3 Brazil Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.5.2.4 Brazil Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)
  • 9.6 Middle East and Africa
    • 9.6.1 MEA Rare Disease Genetic Testing Market estimates and forecast, 2016 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Rare Disease Genetic Testing Market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
      • 9.6.2.2 South Africa Rare Disease Genetic Testing Market estimates and forecast, by technology, 2016 - 2027 (USD Million)
      • 9.6.2.3 South Africa Rare Disease Genetic Testing Market estimates and forecast, by specialty, 2016 - 2027 (USD Million)
      • 9.6.2.4 South Africa Rare Disease Genetic Testing Market estimates and forecast, by end - use, 2016 - 2027 (USD Million)

Chapter 10 Company Profile

  • 10.1 Company Profiles
    • 10.1.1 CENTOGENE N.V.
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Invitae Corporation
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial Performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 3billion, Inc.
      • 10.1.3.1 Company overview
      • 10.1.3.2 Product benchmarking
      • 10.1.3.3 Strategic initiatives
    • 10.1.4 ARUP Laboratories
      • 10.1.4.1 Company overview
      • 10.1.4.2 Product benchmarking
      • 10.1.4.3 Strategic initiatives
    • 10.1.5 Eurofins Scientific
      • 10.1.5.1 Company overview
      • 10.1.5.2 EUROFINS Genoma Group Srl a socio unico
      • 10.1.5.3 Financial Performance
      • 10.1.5.4 Product benchmarking
      • 10.1.5.5 Strategic initiatives
    • 10.1.6 Strand Life Sciences
      • 10.1.6.1 Company overview
      • 10.1.6.2 Product benchmarking
      • 10.1.6.3 Strategic initiatives
    • 10.1.7 Quest Diagnostics Incorporated
      • 10.1.7.1 Company overview
      • 10.1.7.2 Blueprint Genetics Oy
      • 10.1.7.3 Financial Performance
      • 10.1.7.4 Product benchmarking
      • 10.1.7.5 Strategic initiatives
    • 10.1.8 PerkinElmer Genomics
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial Performance
      • 10.1.8.3 Product benchmarking
    • 10.1.9 Ambry Genetics
      • 10.1.9.1 Company overview
      • 10.1.9.2 Product benchmarking
      • 10.1.9.3 Strategic initiatives
    • 10.1.10 Macrogen, Inc.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Product benchmarking
      • 10.1.10.3 Strategic initiatives
    • 10.1.11 Baylor Genetics
      • 10.1.11.1 Company overview
      • 10.1.11.2 Product benchmarking
      • 10.1.11.3 Strategic initiatives
    • 10.1.12 Color Genomics, Inc.
      • 10.1.12.1 Company overview
      • 10.1.12.2 Financial performance
      • 10.1.12.3 Product benchmarking
      • 10.1.12.4 Strategic initiatives
    • 10.1.13 HEALTH NETWORK LABORATORIES
      • 10.1.13.1 Company overview
      • 10.1.13.2 Connective Tissue Gene Tests
      • 10.1.13.2.1 Company overview
      • 10.1.13.3 Product benchmarking
      • 10.1.13.4 Strategic initiatives
    • 10.1.14 PreventionGenetics
      • 10.1.14.1 Company overview
      • 10.1.14.2 Product benchmarking
      • 10.1.14.3 Strategic initiatives
    • 10.1.15 Progenity, Inc.
      • 10.1.15.1 Company overview
      • 10.1.15.2 Product benchmarking
    • 10.1.16 CooperSurgical, Inc.
      • 10.1.16.1 Company overview
      • 10.1.16.2 Genesis Genetics
      • 10.1.16.2.1 Company overview
      • 10.1.16.3 Financial performance
      • 10.1.16.4 Product benchmarking
      • 10.1.16.5 Strategic initiatives
    • 10.1.17 Fulgent Genetics Inc,
      • 10.1.17.1 Company overview
      • 10.1.17.2 Financial Performance
      • 10.1.17.3 Product benchmarking
      • 10.1.17.4 Strategic initiatives
    • 10.1.18 Myriad Genetics, Inc.
      • 10.1.18.1 Company overview
      • 10.1.18.2 Counsyl, Inc.
      • 10.1.18.2.1 Company overview
      • 10.1.18.3 Financial Performance
      • 10.1.18.4 Product benchmarking
      • 10.1.18.5 Strategic initiatives
    • 10.1.19 Laboratory Corporation of America Holdings
      • 10.1.19.1 Company overview
      • 10.1.19.2 Sequenom
      • 10.1.19.2.1 Company overview
      • 10.1.19.3 Financial Performance
      • 10.1.19.3.1 Financial performance (Sequenom)
      • 10.1.19.4 Product benchmarking
      • 10.1.19.5 Strategic initiatives
    • 10.1.20 OPKO Health, Inc.
      • 10.1.20.1 Company overview
      • 10.1.20.2 Bio - Reference Laboratories
      • 10.1.20.2.1 Company overview
      • 10.1.20.2.2 GeneDx
      • 10.1.20.2.2.1 Company overview
      • 10.1.20.2 Financial Performance
      • 10.1.20.3 Product benchmarking
      • 10.1.20.4 Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.